HRSRX Mutual Fund

HRSRX Mutual Fund

NAV$96.59
See how much of HRSRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
$178M
Expense Ratio
1.32%
Dividend Yield (Current)
-
Holdings
115
Inception Date
Jul 7, 2015
Fund Family
Hood River Capital Management LLC
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+11.19%
1 Year+20.10%
3 Year+30.40%
5 Year+16.50%
10 Year+20.61%

Asset Allocation

Stocks: 96.61%
Bonds: 0.10%
Cash: 3.07%
Other: 0.23%
See how much of HRSRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
APLDApplied Digital Corp6.12%
DOCNDigitalocean Holdings Inc4.92%
MTZMastec Inc3.86%
FXFXXFirst Am Treas Obli-X3.07%
BECfd Bloom Energy Corp- A3.05%
Top 10 Concentration: 32.20%Report Date: Jun 30, 2026
Download all 115 holdings for HRSRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$12.96
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

HRSRX Mutual Fund Overview

HRSRX Mutual Fund (Hood River Small Cap Growth Fund Investor Class) is managed by Hood River Capital Management LLC with $178.3M in net assets. HRSRX expense ratio is 1.32%, holding 115 positions across sectors including Information Technology, Industrials, Health Care. Inception date: 2015-07-07.

HRSRX performance shows a YTD return of 11.19%. The 1-year return is 20.10% and the 5-year return is 16.50%.

HRSRX top holdings include Applied Digital Corp (6.1%), Digitalocean Holdings Inc (4.9%), Mastec Inc (3.9%), First Am Treas Obli-X (3.1%), Cfd Bloom Energy Corp- A (3.0%). Go to all HRSRX holdings, HRSRX sectors, or HRSRX dividends.

HRSRX can be compared against other funds. Use HRSRX overlap to find shared positions, or HRSRX vs another fund for a side-by-side view. HRSRX alternatives are available via the screener, along with tax-loss harvesting opportunities.